YU18199A - Postupak za dobijanje hidroksamskih kiselina - Google Patents

Postupak za dobijanje hidroksamskih kiselina

Info

Publication number
YU18199A
YU18199A YU18199A YU18199A YU18199A YU 18199 A YU18199 A YU 18199A YU 18199 A YU18199 A YU 18199A YU 18199 A YU18199 A YU 18199A YU 18199 A YU18199 A YU 18199A
Authority
YU
Yugoslavia
Prior art keywords
hydroxamic acids
preparing hydroxamic
preparing
carboxile
intermediaries
Prior art date
Application number
YU18199A
Other languages
English (en)
Inventor
Joel Michael Hawkins
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU18199A publication Critical patent/YU18199A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Abstract

Ovaj pronalazak se odnosi na postupak za dobijanje hidroksamskih kiselina iz intermedijara hidroksilne kiseline u kojima intermedijar karboksilne kiseline nema reaktivne supstituente kao što su hidroksi ili amino grupe.[This invention refers to the procedure for obtaining hydroxamic acids from intermediaries of carboxile acid has no reactive substituents such as hydroxy or amino group.
YU18199A 1998-04-10 1999-04-08 Postupak za dobijanje hidroksamskih kiselina YU18199A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
YU18199A true YU18199A (sh) 2002-11-15

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
YU18199A YU18199A (sh) 1998-04-10 1999-04-08 Postupak za dobijanje hidroksamskih kiselina

Country Status (38)

Country Link
US (1) US6288246B1 (sh)
EP (1) EP0949244A3 (sh)
JP (1) JPH11343277A (sh)
KR (1) KR100329902B1 (sh)
CN (1) CN1232023A (sh)
AP (1) AP1203A (sh)
AR (1) AR018180A1 (sh)
AU (1) AU747629B2 (sh)
BG (1) BG64154B1 (sh)
BR (1) BR9901089A (sh)
CA (1) CA2268680A1 (sh)
CO (1) CO5070713A1 (sh)
DZ (1) DZ2757A1 (sh)
EA (1) EA002777B1 (sh)
EG (1) EG22263A (sh)
GT (1) GT199900046A (sh)
HR (1) HRP990105A2 (sh)
HU (1) HUP9901041A3 (sh)
ID (1) ID23337A (sh)
IL (1) IL129328A0 (sh)
IN (1) IN192342B (sh)
IS (1) IS5019A (sh)
MA (1) MA24831A1 (sh)
NO (1) NO991672L (sh)
NZ (1) NZ335104A (sh)
OA (1) OA11031A (sh)
PA (1) PA8469301A1 (sh)
PE (1) PE20000418A1 (sh)
PL (1) PL332450A1 (sh)
SG (1) SG125880A1 (sh)
SK (1) SK43699A3 (sh)
TN (1) TNSN99052A1 (sh)
TR (1) TR199900755A2 (sh)
TW (1) TW448147B (sh)
UA (1) UA57750C2 (sh)
UY (1) UY25460A1 (sh)
YU (1) YU18199A (sh)
ZA (1) ZA992631B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
AU2003264355A1 (en) * 2003-08-29 2005-03-29 Basf Aktiengesellschaft Process for production of o-substituted hydroxylamines
CA2933174A1 (en) 2013-12-18 2015-06-25 Brita Lp Filter assembly for filter as you pour filtration
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Ａｌｋ﹘５抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
KR20000068248A (ko) 1996-08-23 2000-11-25 디. 제이. 우드, 스피겔 알렌 제이 아릴설포닐아미노 하이드록삼산 유도체
US6303636B1 (en) 1997-02-03 2001-10-16 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2299355C (en) 1997-08-08 2005-09-27 Pfizer Products Inc. Aryloxyarylsulfonylamino hydroxamic acid derivatives
PT895988E (pt) 1997-08-08 2002-09-30 Pfizer Prod Inc Derivados do acido arilsulfonilamino-hidroxamico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
KR19990083051A (ko) 1999-11-25
AU747629B2 (en) 2002-05-16
BR9901089A (pt) 2000-05-30
AP9901503A0 (en) 1999-06-30
IL129328A0 (en) 2000-02-17
EP0949244A2 (en) 1999-10-13
UA57750C2 (uk) 2003-07-15
HUP9901041A3 (en) 2003-02-28
EG22263A (en) 2002-11-30
PA8469301A1 (es) 2000-09-29
AU2369099A (en) 1999-10-21
AR018180A1 (es) 2001-10-31
TW448147B (en) 2001-08-01
KR100329902B1 (ko) 2002-03-22
SG125880A1 (en) 2006-10-30
EA002777B1 (ru) 2002-08-29
OA11031A (en) 2002-02-07
TNSN99052A1 (fr) 2005-11-10
EP0949244A3 (en) 2001-05-30
CO5070713A1 (es) 2001-08-28
US6288246B1 (en) 2001-09-11
NZ335104A (en) 2000-10-27
BG64154B1 (bg) 2004-02-27
TR199900755A3 (tr) 1999-11-22
ID23337A (id) 2000-04-05
MA24831A1 (fr) 1999-12-31
PE20000418A1 (es) 2000-05-23
GT199900046A (es) 2000-09-15
CN1232023A (zh) 1999-10-20
BG103319A (en) 2001-08-31
NO991672L (no) 1999-10-11
HUP9901041A2 (hu) 2000-03-28
EA199900284A2 (ru) 1999-10-28
UY25460A1 (es) 1999-11-17
NO991672D0 (no) 1999-04-09
AP1203A (en) 2003-09-05
PL332450A1 (en) 1999-10-11
JPH11343277A (ja) 1999-12-14
EA199900284A3 (ru) 2000-04-24
ZA992631B (en) 2000-10-09
SK43699A3 (en) 2000-06-12
DZ2757A1 (fr) 2003-09-15
IN192342B (sh) 2004-04-10
IS5019A (is) 1999-10-11
TR199900755A2 (xx) 1999-11-22
HU9901041D0 (en) 1999-06-28
HRP990105A2 (en) 2000-02-29
CA2268680A1 (en) 1999-10-10

Similar Documents

Publication Publication Date Title
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
CA2269246A1 (en) Substituted tricyclics
CA2372986A1 (en) Process for the condensation of polyamides
PL341088A1 (en) Method of obtaining 8-methoxy-quinolinocarboxylic acids
YU18199A (sh) Postupak za dobijanje hidroksamskih kiselina
HUT77178A (hu) Szubsztituált 3-amino-benzonitrilek, eljárás előállításukra, és eljárás benzatiadiazol-7-karboxilsav előállítására
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
ZA200005110B (en) Process for preparing intermediates.
YU18399A (sh) Postupak alkilacije zaštićenih sulfonamida
PL339296A1 (en) Novel stereoselective methods of obtaining gabapwenting analoques
TW200718702A (en) Process for preparing growth hormone secretagogues
YU31499A (sh) Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline
ATE258547T1 (de) Verfahren zur herstellung von 2-hydroxy-6- trifluormethylpyridin
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
AU7224300A (en) Process for the preparation of cefpodoxime acid
MX9704677A (es) Procedimientos novedosos para preparar intermediarios de inhibidores de encefalinasa y enzima de conversion a angiotensina y sus intermediarios.
AU4757000A (en) Method of producing methoxyimino acetic amide
CZ20011520A3 (cs) Způsob výroby alfa-arylalkanových kyselin
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
MY115259A (en) Process for the preparation of nmda antagonists
RO116896B1 (ro) Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora